Global Chloroquine Products Market Size, Share, Growth, Global Trends, Industry Analysis and Forecast to 2027

Price: 3200/- USD | Published Date: April 9, 2021 |

The global chloroquine products market size was valued at USD 530 million in 2020 and anticipated to grow at a significant CAGR of 4% over the forecast period from 2021 to 2027. The rising prevalence of protozoan infection worldwide primarily drives the chloroquine products market growth. Furthermore increasing clinical trial investigation highlighting positive therapeutic efficacy for the treatment of autoimmune diseases will further accentuate the chloroquine products market growth.

Chloroquine was developed in the early 1940s as an aminoquinolone derivative for the treatment of malaria. It is a broad-spectrum drug that is also utilized for the treatment of all strains of plasmodium infection throughout the globe and also as a prophylactic agent in the treatment of the Zika virus. It exerts its pharmacological effect by inhibiting the action of heme polymerase which eventually results in the buildup of toxic heme in the plasmodium species.

Market Segment Insights:

Protozoan infection is representing the largest market share in the clinical application segment for the chloroquine products market. As per the latest research citings provided by the World Health Organization (WHO) in 2018, approximately 228 million cases of malaria infection were reported worldwide. North Africa, South East Asia, and the Amazon rain forests are the hotspots for malaria infection, where lack of awareness is associated with a high mortality rate associated with malarial infection. Amebiasis is the second largest cause of death associated with parasitic infection, eventually causing the death of 100,000 people throughout the globe each year. Autoimmune disease is keen to record exemplary market growth in the near future on account of the growing incidence of rheumatoid arthritis worldwide. According to the latest statistics provided by the National Institute of Health (NIH), the annual incidence rate of rheumatoid arthritis is 3 cases per 10,000 people worldwide.

Chloroquine Products Market Size and Forecast

To know more about the study, request a report sample

Hospital pharmacy is currently dominating the distribution channel segment for chloroquine products market. The drug is associated with a high degree of cellular toxicity and hence precise compounding by hospital pharmacists in accordance with the doctor’s prescription is mandatory to avoid fatal outcomes. Retail pharmacy is expected to register excellent market growth during the forecast period majorly due to the flourishing generic drugs market in the developing regions and the ability to provide affordable medication to people residing in remote locations.

The chloroquine products comprehensive study offers an in-depth analysis of industry trends, market size, competitive analysis, and market forecast – 2020 to 2027. Research Corridor report provides detailed premium insight into the global market and reveals the potential revenue streams, commercial prospects, market drivers, challenges, opportunities, issues, and events affecting the industry. In addition, the report has a dedicated section covering market forecasts and analysis for leading geographies, profiles of major companies operating in the market and expert opinion obtained from interviews with industry executives and experts from prominent companies.

The chloroquine products market research report presents the analysis of each segment from 2018 to 2027 considering 2020 as the base year for the research. The compounded annual growth rate (CAGR) for each respective segment is calculated for the forecast period from 2021 to 2027.

Historical & Forecast Period

  • 2018-19 – Historical Year
  • 2020 – Base Year
  • 2021-2027 – Forecast Period

Global Chloroquine Products Market Segmentation:

By Clinical Application:

  • Protozoan Infection
  • Autoimmune Diseases
  • Others

By Distribution Channel:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Others

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Geographic Coverage:

The Asia Pacific is presently leading the geography segment for the chloroquine products market. The rising prevalence of protozoan infection in the South East Asia region primarily drives the market growth. Topical weather and monsoon climate provide teeming grounds for malarial and amoebiasis parasites, hence it increases the demand for chloroquine products market. Furthermore, the flourishing generic drugs market further propels the chloroquine products market. Latin America holds the second-largest market share in the regional segment chiefly due to rising public health awareness resulting in early screening and treatment for protozoan infection and rising prevalence of malaria infection in the amazon rain forest. North America is anticipated to be the fastest-growing regional segment for the chloroquine products market. Affordable reimbursement scenario and supportive regulatory environment provided by the USFDA for the sale and distribution of chloroquine products drive the market growth in the region.

Market Competition Assessment:

Key players operating in the global chloroquine products market are Recipharm AB, Bayer AG, Sandoz, Inc., Teva Pharmaceutical Industries Ltd., and Merck & Co., Inc. Companies are exploring markets by expansion, new investment, the introduction of new services, and collaboration as their preferred strategies. Players are exploring new geography through expansion and acquisition to gain a competitive advantage through joint synergy.

List of Key Companies:

  • Recipharm AB
  • Bayer AG
  • Sandoz, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi Aventis
  • IPCA Laboratories
  • Cadila Healthcare
  • Merck & Co., Inc.
  • Indofarma
  • Alliance Pharmaceuticals

Key Questions Answered by Chloroquine Products Market Report:

  • Global chloroquine products market forecasts from 2021-2027
  • Regional chloroquine products market forecasts from 2021-2027 covering Asia-Pacific, North America, Europe, Middle East and Africa, and Latin America
  • Country-level forecasts from 2021-2027 covering 15 major countries from the aforementioned regions
  • Chloroquine products submarket forecasts from 2021-2027 covering the market by clinical application, by distribution channel, and geography
  • Various industry models such as SWOT analysis, Value Chain Analysis pertaining to chloroquine products market
  • Analysis of the key factors driving and restraining the growth of the global, regional and country-level chloroquine products markets from 2021-2027
  • Competitive Landscape and market positioning of top 10 players operating in the chloroquine products market
Table of Content:

Chapter 1. Introduction


1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Scope
1.3.1. Market Segmentation
1.3.2. Years Considered for the Study
1.4. Currency
1.5. Limitation
1.6. Market Stakeholders

 

Chapter 2. Research Methodology


2.1. Market Size Estimation
2.2. Market Breakdown and Data Triangulation
2.3. Market Share Estimation
2.4. Key Data From Secondary Sources
2.5. Key Data From Primary Sources
2.6. Key Industry Insights
2.7. Assumptions for the Study

 

Chapter 3. Executive Summary


3.1. Global Chloroquine Products Market Snapshot
3.2. Global Chloroquine Products Market, by Clinical Application, 2019 (US$ Mn)
3.3. Global Chloroquine Products Market, By Distribution Channel, 2019 (US$ Mn)
3.4. Global Chloroquine Products Market, by Geography, 2019 (US$ Mn)

 

Chapter 4. Chloroquine Products Market: Dynamics and Future Outlook


4.1. Market Overview
4.2. Drivers
4.3. Challenges
4.4. Opportunities
4.5. Attractive Investment Proposition, by Geography, 2019

 

Chapter 5. Global Chloroquine Products Market, by Clinical Application


5.1. Introduction
5.2. Protozoan Infection
5.3. Autoimmune Diseases
5.4. Others

 

Chapter 6. Global Chloroquine Products Market, By Distribution Channel


6.1. Introduction
6.2. Hospital Pharmacy
6.3. Retail Pharmacy
6.4. Others

 

Chapter 7. Global Chloroquine Products Market, by Geography


7.1. Introduction
7.1. North America Chloroquine Products Market Analysis, 2017 – 2027
7.1.1. North America Chloroquine Products Market, by Clinical Application, 2017 – 2027 (US$ Mn)
7.1.2. North America Chloroquine Products Market, By Distribution Channel, 2017 – 2027 (US$ Mn)
7.1.3. North America Chloroquine Products Market, by Country, 2017 – 2027 (US$ Mn)
7.1.3.1. U.S.
7.1.3.2. Canada
7.2. Europe Chloroquine Products Market Analysis, 2017 – 2027
7.2.1. Europe Chloroquine Products Market, by Clinical Application, 2017 – 2027 (US$ Mn)
7.2.2. Europe Chloroquine Products Market, By Distribution Channel, 2017 – 2027 (US$ Mn)
7.2.3. Europe Chloroquine Products Market, by Country, 2017 – 2027 (US$ Mn)
7.2.3.1. U.K.
7.2.3.2. Germany
7.2.3.3. Russia
7.2.3.4. France
7.2.3.5. Italy
7.2.3.6. Spain
7.2.3.7. Ukraine
7.2.3.8. Rest of Europe
7.3. Asia Pacific Chloroquine Products Market Analysis, 2017 – 2027
7.3.1. Asia Pacific Chloroquine Products Market, by Clinical Application, 2017 – 2027 (US$ Mn)
7.3.2. Asia Pacific Chloroquine Products Market, By Distribution Channel, 2017 – 2027 (US$ Mn)
7.3.3. Asia Pacific Chloroquine Products Market, by Country, 2017 – 2027 (US$ Mn)
7.3.3.1. China
7.3.3.2. Japan
7.3.3.3. Rest of Asia Pacific
7.4. Latin America Chloroquine Products Market Analysis, 2017 – 2027
7.4.1. Latin America Chloroquine Products Market, by Clinical Application, 2017 – 2027 (US$ Mn)
7.4.2. Latin America Chloroquine Products Market, By Distribution Channel, 2017 – 2027 (US$ Mn)
7.4.3. Latin America Chloroquine Products Market, by Country, 2017 – 2027 (US$ Mn)
7.4.3.1. Brazil
7.4.3.2. Mexico
7.4.3.3. Rest of Latin America
7.5. Middle East and Africa Chloroquine Products Market Analysis, 2017 – 2027
7.5.1. MEA Chloroquine Products Market, by Clinical Application, 2017 – 2027 (US$ Mn)
7.5.2. MEA Chloroquine Products Market, By Distribution Channel, 2017 – 2027 (US$ Mn)
7.5.3. MEA Chloroquine Products Market, by Country/Region, 2017 – 2027 (US$ Mn)
7.5.3.1. GCC
7.5.3.2. Rest of MEA

 

Chapter 8. Company Profiles


8.1. Recipharm AB
8.1.1. Business Description
8.1.2. Financial Information (Subject to data availability)
8.1.3. Product Portfolio
8.1.4. Recent Developments
8.1.5. SWOT Analysis
8.2. Bayer AG
8.3. Sandoz, Inc.
8.4. Teva Pharmaceutical Industries Ltd.
8.5. Sanofi Aventis
8.6. IPCA Laboratories
8.7. Cadila Healthcare
8.8. Merck & Co., Inc.
8.9. Indofarma
8.10. Alliance Pharmaceuticals

To know more about the study, request a report sample

List of Figures:

FIG. 1 Chloroquine Products: Market Segmentation
FIG. 2 Global Chloroquine Products Market, by Clinical Application, 2019 (US$ Mn)
FIG. 3 Global Chloroquine Products Market, By Distribution Channel, 2019 (US$ Mn)
FIG. 4 Global Chloroquine Products Market, by Geography, 2019 (US$ Mn)
FIG. 5 Attractive Investment Proposition: by Geography, 2019
FIG. 6 Global Protozoan Infection Chloroquine Products Market, 2017 – 2027 (US$ Mn)
FIG. 7 Global Autoimmune Diseases Chloroquine Products Market, 2017 – 2027 (US$ Mn)
FIG. 8 Global Other Clinical Application Chloroquine Products Market, 2017 – 2027 (US$ Mn)
FIG. 9 Global Hospital Pharmacy Market for Chloroquine Products, 2017 – 2027 (US$ Mn)
FIG. 10 Global Retail Pharmacy Market for Chloroquine Products, 2017 – 2027 (US$ Mn)
FIG. 11 Global Other Distribution Channel Market for Chloroquine Products, 2017 – 2027 (US$ Mn)
FIG. 12 U.S. Chloroquine Products Market, 2017 – 2027 (US$ Mn)
FIG. 13 Canada Chloroquine Products Market, 2017 – 2027 (US$ Mn)
FIG. 14 U.K. Chloroquine Products Market, 2017 – 2027 (US$ Mn)
FIG. 15 Germany Chloroquine Products Market, 2017 – 2027 (US$ Mn)
FIG. 16 Russia Chloroquine Products Market, 2017 – 2027 (US$ Mn)
FIG. 17 France Chloroquine Products Market, 2017 – 2027 (US$ Mn)
FIG. 18 Italy Chloroquine Products Market, 2017 – 2027 (US$ Mn)
FIG. 19 Spain Chloroquine Products Market, 2017 – 2027 (US$ Mn)
FIG. 20 Ukraine Chloroquine Products Market, 2017 – 2027 (US$ Mn)
FIG. 21 Rest of Europe Chloroquine Products Market, 2017 – 2027 (US$ Mn)
FIG. 22 China Chloroquine Products Market, 2017 – 2027 (US$ Mn)
FIG. 23 Japan Chloroquine Products Market, 2017 – 2027 (US$ Mn)
FIG. 24 Rest of Asia Pacific Chloroquine Products Market, 2017 – 2027 (US$ Mn)
FIG. 25 Brazil Chloroquine Products Market, 2017 – 2027 (US$ Mn)
FIG. 26 Mexico Chloroquine Products Market, 2017 – 2027 (US$ Mn)
FIG. 27 Rest of Latin America Chloroquine Products Market, 2017 – 2027 (US$ Mn)
FIG. 28 GCC Chloroquine Products Market, 2017 – 2027 (US$ Mn)
FIG. 29 Rest of MEA Chloroquine Products Market, 2017 – 2027 (US$ Mn)
FIG. 30 Chloroquine Products Market: Research Methodology

To know more about the study, request a report sample

List of Tables:

TABLE 1 Global Chloroquine Products Market Snapshot
TABLE 2 Global Chloroquine Products Market, by Clinical Application, 2017 – 2027 (US$ Mn)
TABLE 3 Global Chloroquine Products Market, By Distribution Channel, 2017 – 2027 (US$ Mn)
TABLE 4 Global Chloroquine Products Market, by Geography, 2017 – 2027 (US$ Mn)
TABLE 5 North America Chloroquine Products Market, by Clinical Application, 2017 – 2027 (US$ Mn)
TABLE 6 North America Chloroquine Products Market, By Distribution Channel, 2017 – 2027 (US$ Mn)
TABLE 7 North America Chloroquine Products Market, by Country, 2017 – 2027 (US$ Mn)
TABLE 8 Europe Chloroquine Products Market, by Clinical Application, 2017 – 2027 (US$ Mn)
TABLE 9 Europe Chloroquine Products Market, By Distribution Channel, 2017 – 2027 (US$ Mn)
TABLE 10 Europe Chloroquine Products Market, by Country, 2017 – 2027 (US$ Mn)
TABLE 11 Asia Pacific Chloroquine Products Market, by Clinical Application, 2017 – 2027 (US$ Mn)
TABLE 12 Asia Pacific Chloroquine Products Market, By Distribution Channel, 2017 – 2027 (US$ Mn)
TABLE 13 Asia Pacific Chloroquine Products Market, by Country, 2017 – 2027 (US$ Mn)
TABLE 14 Latin America Chloroquine Products Market, by Clinical Application, 2017 – 2027 (US$ Mn)
TABLE 15 Latin America Chloroquine Products Market, By Distribution Channel, 2017 – 2027 (US$ Mn)
TABLE 16 Latin America Chloroquine Products Market, by Country, 2017 – 2027 (US$ Mn)
TABLE 17 Middle East and Africa Chloroquine Products Market, by Clinical Application, 2017 – 2027 (US$ Mn)
TABLE 18 Middle East and Africa Chloroquine Products Market, By Distribution Channel, 2017 – 2027 (US$ Mn)
TABLE 19 Middle East and Africa Chloroquine Products Market, by Country/Region, 2017 – 2027 (US$ Mn)
TABLE 20 Recipharm AB.: Company Snapshot (Business Description; Financial Information; Product Portfolio; SWOT Analysis; Recent Developments)
TABLE 21 Bayer AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; SWOT Analysis; Recent Developments)
TABLE 22 Sandoz, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; SWOT Analysis; Recent Developments)
TABLE 23 Teva Pharmaceutical Industries Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; SWOT Analysis; Recent Developments)
TABLE 24 Sanofi Aventis: Company Snapshot (Business Description; Financial Information; Product Portfolio; SWOT Analysis; Recent Developments)
TABLE 25 IPCA Laboratories: Company Snapshot (Business Description; Financial Information; Product Portfolio; SWOT Analysis; Recent Developments)
TABLE 26 Cadila Healthcare: Company Snapshot (Business Description; Financial Information; Product Portfolio; SWOT Analysis; Recent Developments)
TABLE 27 Merck & Co., Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; SWOT Analysis; Recent Developments)
TABLE 28 Indofarma: Company Snapshot (Business Description; Financial Information; Product Portfolio; SWOT Analysis; Recent Developments)
TABLE 29 Alliance Pharmaceuticals: Company Snapshot (Business Description; Financial Information; Product Portfolio; SWOT Analysis; Recent Developments)
Fill the given form to inquiry before buying for Chloroquine Products Market Report

Your Designtaion (required):


(Additional country analysis and conmapny analysis will be added according to request, please read our FAQs below:)(Reports covers the COVID-19 impacts on the market)

Request Report Sample
Inquiry Before Buying



Frequently Asked Questions (FAQs):
A. Yes, we provide customization with every report to fulfill your market research requirement.
A. No, generally we don’t charge for report customization.
A. Yes, we will add the more coutries analysis in the report, please mention the countries you are looking.
A. Yes, we provide research support for all our clients to resolve their issue regarding the report.
A. Yes, you can purchase only a regional or a country market report with our best price which is less than the global report.
A. Yes, we provide a better discount for startups and individuals.
A. Our database consists of over 70,000 market research reports; if still not available on the website, feel free to write us. Our team will be happy to assist you in the same. Let us know if you are looking for the dataset.
(For more information, feel free to write us at sales@researchcorridor.com)
Select License Type
$3600/- Single User License
$4800/- Multi User License
$6400/- Corporate License

Paypal Certified Payment
Why To Choose Us:
  • Markets in over 150 countries analyzed granularly
  • 35% of our total client are returning clients
  • 100,000+ data points in our comprehensive database
  • 24x5 availability - we are always there when you need us
  • Our expert team will assist you with all research need and customization
  • Our expert research analysts will resolve your every query before and after purchasing the report
  • We focus on the accuracy and quality of the report
  • Our analyst will provide deep insights into the report

Impacts of COVID-19
COVID-19 Impact on the Chloroquine Products Market

For Any Assitance

Call Us: +1 520-686-7060
Email: sales@researchcorridor.com

Our Clients